John L. Kulp

1.4k total citations
41 papers, 1.1k citations indexed

About

John L. Kulp is a scholar working on Molecular Biology, Epidemiology and Biomaterials. According to data from OpenAlex, John L. Kulp has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Epidemiology and 10 papers in Biomaterials. Recurrent topics in John L. Kulp's work include Hepatitis B Virus Studies (8 papers), Hepatitis C virus research (8 papers) and Chemical Synthesis and Analysis (7 papers). John L. Kulp is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Hepatitis C virus research (8 papers) and Chemical Synthesis and Analysis (7 papers). John L. Kulp collaborates with scholars based in United States, China and Japan. John L. Kulp's co-authors include John Spencer Evans, Paramjit S. Arora, Kang Chen, Deyun Wang, Kathryn J. Wahl, Daniel E. Barlow, Gary H. Dickinson, Daniel Rittschof, Beatriz Orihuela and Mehmet Sarıkaya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

John L. Kulp

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John L. Kulp United States	18	528	296	174	163	130	41	1.1k
Heinrich Hohenberg Germany	17	447 0.8×	101 0.3×	342 2.0×	177 1.1×	239 1.8×	23	1.4k
M. A. Alsina Spain	19	965 1.8×	176 0.6×	215 1.2×	68 0.4×	59 0.5×	134	1.5k
Michael D. Altman United States	23	826 1.6×	296 1.0×	55 0.3×	320 2.0×	164 1.3×	49	1.7k
Isabel Haro Spain	23	998 1.9×	167 0.6×	402 2.3×	203 1.2×	236 1.8×	189	2.1k
Arthur J. Rowe United Kingdom	27	1.1k 2.1×	128 0.4×	168 1.0×	76 0.5×	134 1.0×	77	2.0k
Ira B. Dicker United States	24	462 0.9×	61 0.2×	96 0.6×	492 3.0×	102 0.8×	53	1.5k
Osamu Moriya Japan	19	237 0.4×	76 0.3×	121 0.7×	89 0.5×	296 2.3×	106	1.3k
Charlotte Larsson Sweden	16	680 1.3×	101 0.3×	121 0.7×	148 0.9×	66 0.5×	21	1.5k
Jacob T. Martin United States	16	296 0.6×	64 0.2×	289 1.7×	95 0.6×	223 1.7×	23	907

Countries citing papers authored by John L. Kulp

Since Specialization

Citations

This map shows the geographic impact of John L. Kulp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John L. Kulp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John L. Kulp more than expected).

Fields of papers citing papers by John L. Kulp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John L. Kulp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John L. Kulp. The network helps show where John L. Kulp may publish in the future.

Co-authorship network of co-authors of John L. Kulp

This figure shows the co-authorship network connecting the top 25 collaborators of John L. Kulp. A scholar is included among the top collaborators of John L. Kulp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John L. Kulp. John L. Kulp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tolufashe, Gideon F., et al.. (2025). Computational Approaches to Predict Hepatitis B Virus Capsid Protein Mutations That Confer Resistance to Capsid Assembly Modulators. Viruses. 17(3). 332–332. 1 indexed citations

Ruiz, Francesc X., Stacy Remiszewski, Matthew J. Todd, et al.. (2025). Structural basis for sirtuin 2 activity and modulation: Current state and opportunities. Journal of Biological Chemistry. 301(7). 110274–110274.

Shenk, Thomas, John L. Kulp, & Lillian W. Chiang. (2024). Drugs Targeting Sirtuin 2 Exhibit Broad-Spectrum Anti-Infective Activity. Pharmaceuticals. 17(10). 1298–1298.

Remiszewski, Stacy, Matthew J. Todd, John L. Kulp, et al.. (2023). An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity. Journal of Clinical Investigation. 133(12). 14 indexed citations

Kulp, John L., et al.. (2023). BMaps: A Web Application for Fragment-Based Drug Design and Compound Binding Evaluation. Journal of Chemical Information and Modeling. 63(14). 4229–4236. 2 indexed citations

Chen, Junjun, Julia Ma, Hui Liu, et al.. (2021). Synthesis of 4-oxotetrahydropyrimidine-1(2H)-carboxamides derivatives as capsid assembly modulators of hepatitis B virus. Medicinal Chemistry Research. 30(2). 459–472. 6 indexed citations

Luo, Yue, Junjun Cheng, Zhanying Hu, et al.. (2021). Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators. Antiviral Research. 191. 105080–105080. 17 indexed citations

Guan, Hancheng, Manunya Nuth, Vivian Lee, et al.. (2020). Herpes Simplex Virus-1 infection in human primary corneal epithelial cells is blocked by a stapled peptide that targets processive DNA synthesis. The Ocular Surface. 19. 313–321. 9 indexed citations

Zhang, Xiaohui, Bowei Liu, Liudi Tang, et al.. (2019). Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist. ACS Infectious Diseases. 5(7). 1139–1149. 54 indexed citations

10.

Wu, Shuo, Yue Luo, John L. Kulp, et al.. (2018). CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: Implications for mechanism of inhibiting pgRNA packaging. Antiviral Research. 159. 1–12. 23 indexed citations

11.

Zhang, Xuexiang, Junjun Cheng, Julia Ma, et al.. (2018). Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors. ACS Infectious Diseases. 5(5). 759–768. 41 indexed citations

12.

Fears, Kenan P., Manoj K. Kolel‐Veetil, Daniel E. Barlow, et al.. (2018). High-performance nanomaterials formed by rigid yet extensible cyclic β-peptide polymers. Nature Communications. 9(1). 4090–4090. 16 indexed citations

13.

Nuth, Manunya, Hancheng Guan, Yuhong Xiao, et al.. (2018). Mutation and structure guided discovery of an antiviral small molecule that mimics an essential C-Terminal tripeptide of the vaccinia D4 processivity factor. Antiviral Research. 162. 178–185. 8 indexed citations

14.

Liu, Bowei, Liudi Tang, Xiaohui Zhang, et al.. (2017). A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists. Antiviral Research. 147. 37–46. 61 indexed citations

15.

Kulp, John L., et al.. (2017). Hot-spot identification on a broad class of proteins and RNA suggest unifying principles of molecular recognition. PLoS ONE. 12(8). e0183327–e0183327. 5 indexed citations

16.

Dickson, John K., Thomas E. Barta, Brian Grella, et al.. (2017). Design, synthesis and biological evaluation of renin inhibitors guided by simulated annealing of chemical potential simulations. Bioorganic & Medicinal Chemistry. 25(15). 3947–3963. 4 indexed citations

17.

Emert‐Sedlak, Lori A., Haibin Shi, John L. Kulp, et al.. (2016). Synthesis and evaluation of orally active small molecule HIV-1 Nef antagonists. Bioorganic & Medicinal Chemistry Letters. 26(5). 1480–1484. 15 indexed citations

18.

Wilkinson, Sean R., et al.. (2015). A computational chemistry perspective on the current status and future direction of hepatitis B antiviral drug discovery. Antiviral Research. 123. 204–215. 14 indexed citations

19.

Kulp, John L., et al.. (2012). A fragment-based approach to the SAMPL3 Challenge. Journal of Computer-Aided Molecular Design. 26(5). 583–594. 17 indexed citations

20.

Kulp, John L. & Thomas D. Clark. (2009). Engineering a β‐Helical d,l‐Peptide for Folding in Polar Media. Chemistry - A European Journal. 15(44). 11867–11877. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact